Clinical trial
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
NCT02417142
Study timeline
Study start (actual)2014-09-01Date precision: month
Registry last updated2022-01-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
ExenatideDRUG · verified · RxNorm: exenatide
PlaceboDRUG
Sponsors & collaborators
University of Massachusetts, Worcesterlead sponsor
Stanley Medical Research Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02417142 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.